Cargando…
Sphingosine Kinase: A Novel Putative Target for the Prevention of Infection-Triggered Preterm Birth
Preterm birth is defined as any delivery before 37 complete weeks of gestation. It is a universal challenge in the field of obstetrics owing to its high rate of mortality, long-term morbidity, associated human suffering and economic burden. In the United States, about 12.18% deliveries in 2009 were...
Autores principales: | Vyas, Vibhuti, Ashby, Charles R., Reznik, Sandra E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681286/ https://www.ncbi.nlm.nih.gov/pubmed/23818902 http://dx.doi.org/10.1155/2013/302952 |
Ejemplares similares
-
New hope for preventing preterm birth: The promise of vaginal nanoformulations
por: Reznik, Sandra E.
Publicado: (2022) -
The Matrix Metalloproteases and Endothelin-1 in Infection-Associated Preterm Birth
por: Olgun, Nicole S., et al.
Publicado: (2010) -
17-α Hydroxyprogesterone Nanoemulsifying Preconcentrate-Loaded Vaginal Tablet: A Novel Non-Invasive Approach for the Prevention of Preterm Birth
por: Patki, Manali, et al.
Publicado: (2019) -
Vaginal Nanoformulations for the Management of Preterm Birth
por: Mir, Asad, et al.
Publicado: (2022) -
Sphingosine kinase 1 as an anticancer therapeutic target
por: Gao, Ying, et al.
Publicado: (2015)